-9.10 (-0.77%) Dr Reddy's Laboratories has informed that the Exchange had sought clarification with respect to news article appearing on https://economictimes.indiatimes.com dated March 31, 2022 titled ‘Himachal Pradesh high court restrains DRL from selling BI’s diabetic drug Jardiance’. Dr Reddys Laboratory’s response is enclosed.
The above information is a part of company’s filings submitted to BSE.